Literature DB >> 30546667

Complete response to rivaroxaban in a case of invaginated thrombus thought to have extended through a patent foramen ovale with an accompanying pulmonary embolism.

Tadasuke Chitose1, Takuro Yamashita1, Mitsutoshi Miura1, Koshi Matsuyama1.   

Abstract

Occurrence of paradoxical embolisms caused by deep venous thrombosis (DVT) is often encountered in the clinical setting. However, a thrombus that is invaginated from the right atrium into the left atrium (an impending paradoxical embolism) is rare. We report a case of an 80-year-old woman who had the complication of an impending paradoxical embolism and a pulmonary embolism. Because an indication of new anticoagulants was expanded to treatment of venous thromboembolism and oral administration became available, we initially administered edoxaban, which did not cause the thrombus to disappear. Therefore, we switched to rivaroxaban, which resulted in successful elimination of the thrombus. Our findings indicate the differences in effects between each novel oral anticoagulant. <Learning objective: Paradoxical thrombosis is a common clinical occurrence. However, we believe that our case is rare because we were able to collect images confirming that the thrombus had passed through the interatrial septum and was nearly invaginated into the left atrium. Beyond warfarin, current anticoagulant therapy options may involve the factor Xa blockers edoxaban or rivaroxaban for patients with venous thromboembolism. Findings in our case suggested that there are different effects for novel oral anticoagulants in treatment of venous thromboembolism.>.

Entities:  

Keywords:  Impending paradoxical embolism; Novel oral anticoagulant; Pulmonary embolism; Rivaroxaban

Year:  2016        PMID: 30546667      PMCID: PMC6282875          DOI: 10.1016/j.jccase.2016.03.020

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  7 in total

1.  Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

Authors:  Harry R Büller; Hervé Décousus; Michael A Grosso; Michele Mercuri; Saskia Middeldorp; Martin H Prins; Gary E Raskob; Sebastian M Schellong; Lee Schwocho; Annelise Segers; Minggao Shi; Peter Verhamme; Phil Wells
Journal:  N Engl J Med       Date:  2013-08-31       Impact factor: 91.245

Review 2.  Paradoxical embolism.

Authors:  Stephan Windecker; Stefan Stortecky; Bernhard Meier
Journal:  J Am Coll Cardiol       Date:  2014-07-29       Impact factor: 24.094

3.  Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013).

Authors: 
Journal:  Circ J       Date:  2014-06-26       Impact factor: 2.993

4.  Oral rivaroxaban for symptomatic venous thromboembolism.

Authors:  Rupert Bauersachs; Scott D Berkowitz; Benjamin Brenner; Harry R Buller; Hervé Decousus; Alex S Gallus; Anthonie W Lensing; Frank Misselwitz; Martin H Prins; Gary E Raskob; Annelise Segers; Peter Verhamme; Phil Wells; Giancarlo Agnelli; Henri Bounameaux; Alexander Cohen; Bruce L Davidson; Franco Piovella; Sebastian Schellong
Journal:  N Engl J Med       Date:  2010-12-03       Impact factor: 91.245

Review 5.  Thrombosis in multiple myeloma.

Authors:  Sigurdur Yngvi Kristinsson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

Review 6.  Surgical or medical treatment for thrombus straddling the patent foramen ovale: impending paradoxical embolism? Report of four clinical cases and literature review.

Authors:  Elodie Fauveau; Ariel Cohen; Nicolas Bonnet; Karim Gacem; Hervé Lardoux
Journal:  Arch Cardiovasc Dis       Date:  2008-11-18       Impact factor: 2.340

7.  Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program.

Authors:  Norikazu Yamada; Atsushi Hirayama; Hideaki Maeda; Satoru Sakagami; Hiroo Shikata; Martin H Prins; Anthonie Wa Lensing; Masaharu Kato; Junichi Onuma; Yuki Miyamoto; Kazuma Iekushi; Mariko Kajikawa
Journal:  Thromb J       Date:  2015-01-17
  7 in total
  1 in total

1.  Pulmonary embolism with migrating thrombus through patent foramen ovale: A case for a mixed pharmacological and percutaneous management.

Authors:  Gloria Santangelo; Alfonso Ielasi; Francesco Pattarino; Antonio Tommaso Saino; Pasquale Antonio Scopelliti; Maurizio Tespili
Journal:  J Cardiol Cases       Date:  2018-09-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.